MetaCap

Pacific Biosciences of California (PACB) vs Rapid Micro Biosystems (RPID)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Pacific Biosciences of California (PACB) has outperformed Rapid Micro Biosystems (RPID) over the past year, losing 26.6% versus a loss of 82.4%. Over five years, PACB leads with a -93.0% price change compared with -94.4% for RPID. Pacific Biosciences of California is the larger company by market cap ($508.9 million vs $37.4 million), about 13.6 times the size, while Rapid Micro Biosystems is growing revenue faster (+19.7% vs +3.9%).

Rapid Micro Biosystems converts more of its revenue into profit, with a net margin of -140.3% versus -341.5%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

PACB-26.58%RPID-82.37%
+36%-27%-91%
Nov 21, 20251 yearNov 20, 2026
PACB-93.84%RPID-95.40%
+5%-48%-101%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

PACB versus RPID key metrics
MetricPACBRPID
Share price$1.63$0.735
Market cap$508.95M$37.37M
1-day change-7.39%-0.04%
YTD return-12.83%-74.66%
1-year return-26.58%-82.37%
5-year return-93.01%-94.41%
EPS (TTM)$-0.42$-1.06
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$160.00M$33.59M
Revenue growth (YoY)+3.89%+19.74%
Net income (latest FY)$-546.38M$-47.12M
Gross margin28.61%—
Operating margin-346.15%-141.10%
Net margin-341.47%-140.30%
52-week high$3.44$4.94
52-week low$1.07$0.58
Distance from 52-week high-52.62%-85.12%
Analyst consensusbuystrong_buy
Avg. price target upside+68.10%+682.31%
Average volume13.23M577.05K
Shares outstanding312.24M46.34M
Employees485171
SectorIndustrialsIndustrials
IndustryBiotechnology: Laboratory Analytical InstrumentsBiotechnology: Laboratory Analytical Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Pacific Biosciences of California is about 13.6 times larger than Rapid Micro Biosystems by market value ($508.95M vs $37.37M).
  • PACB has outperformed RPID by 55.8 percentage points over the past year.
  • Rapid Micro Biosystems is more profitable, keeping -140.3 cents of every revenue dollar as net income versus -341.5 cents for Pacific Biosciences of California.
  • Rapid Micro Biosystems grew revenue faster in its latest fiscal year (+19.74% vs +3.89%).

About Pacific Biosciences of California

PACB stock →

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems.

Industrials · Biotechnology: Laboratory Analytical Instruments · 485 employees

About Rapid Micro Biosystems

RPID stock →

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.

Industrials · Biotechnology: Laboratory Analytical Instruments · 171 employees

PACB vs RPID FAQ

Which is bigger, Pacific Biosciences of California or Rapid Micro Biosystems?

Pacific Biosciences of California (PACB) is larger, with a market capitalization of $508.95M compared with $37.37M for Rapid Micro Biosystems (RPID).

Which stock has performed better over the past year, PACB or RPID?

PACB returned -26.58% over the past 12 months, compared with -82.37% for RPID (price return, excluding dividends). Past performance does not predict future results.

Are Pacific Biosciences of California and Rapid Micro Biosystems in the same industry?

Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.

More comparisons